IL315993A - נגזרת טטראהידרונפתלן - Google Patents

נגזרת טטראהידרונפתלן

Info

Publication number
IL315993A
IL315993A IL315993A IL31599324A IL315993A IL 315993 A IL315993 A IL 315993A IL 315993 A IL315993 A IL 315993A IL 31599324 A IL31599324 A IL 31599324A IL 315993 A IL315993 A IL 315993A
Authority
IL
Israel
Prior art keywords
ref
substituted
alkyl
amino
unsubstituted
Prior art date
Application number
IL315993A
Other languages
English (en)
Inventor
KANAIYoshikatsu
Ueharakohki
Ohtayoichiro
TakenakaHiroshi
Masuishin
Original Assignee
Atransen Pharma Ltd
Stella Pharma Corp
Univ Osaka
KANAIYoshikatsu
Ueharakohki
Ohtayoichiro
TakenakaHiroshi
Masuishin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atransen Pharma Ltd, Stella Pharma Corp, Univ Osaka, KANAIYoshikatsu, Ueharakohki, Ohtayoichiro, TakenakaHiroshi, Masuishin filed Critical Atransen Pharma Ltd
Publication of IL315993A publication Critical patent/IL315993A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/50—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83—Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL315993A 2022-03-31 2023-03-30 נגזרת טטראהידרונפתלן IL315993A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022058114 2022-03-31
PCT/JP2023/013197 WO2023190878A1 (ja) 2022-03-31 2023-03-30 テトラヒドロナフタレン誘導体

Publications (1)

Publication Number Publication Date
IL315993A true IL315993A (he) 2024-11-01

Family

ID=88202795

Family Applications (1)

Application Number Title Priority Date Filing Date
IL315993A IL315993A (he) 2022-03-31 2023-03-30 נגזרת טטראהידרונפתלן

Country Status (8)

Country Link
US (1) US20260035339A1 (he)
EP (1) EP4501906A1 (he)
JP (1) JPWO2023190878A1 (he)
KR (1) KR20240167916A (he)
CN (1) CN118974007A (he)
AU (1) AU2023246242A1 (he)
IL (1) IL315993A (he)
WO (1) WO2023190878A1 (he)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023149495A (ja) * 2022-03-31 2023-10-13 Ａｔｒａｎｓｅｎ Ｐｈａｒｍａ株式会社 Ｌ型アミノ酸トランスポーター１特異的化合物の製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101768086B (zh) * 2008-12-29 2014-03-26 北京富龙康泰生物技术有限公司 氨基甲醇衍生物及其盐类化合物及其合成方法和其药物用途
US8907128B2 (en) * 2010-08-03 2014-12-09 Stella Pharma Corporation Boron compound with amino acid skeleton containing cyclo ring-type ring
PL215215B1 (pl) * 2010-12-14 2013-11-29 Univ Mikolaja Kopernika Kwas 2-amino-6-dihydroksyborylo-1,2,3,4-tetrahydronaftaleno-2-karboksylowy i sposób jego wytwarzania
AU2018312327B2 (en) * 2017-08-04 2022-05-12 Osaka University Production method for radiolabeled aryl compound

Also Published As

Publication number Publication date
US20260035339A1 (en) 2026-02-05
CN118974007A (zh) 2024-11-15
KR20240167916A (ko) 2024-11-28
JPWO2023190878A1 (he) 2023-10-05
AU2023246242A1 (en) 2024-10-10
WO2023190878A1 (ja) 2023-10-05
EP4501906A1 (en) 2025-02-05

Similar Documents

Publication Publication Date Title
AU2020241258B2 (en) Novel small molecule inhibitors of TEAD transcription factors
IL298753A (he) תרכובת אימידאזול הטרוארומטית מחומשת ושימוש בה
IL266126A (he) תרכובת פירידון כמעכב c–met
JP7099672B2 (ja) 医薬化合物
IL278281B1 (he) צורה גבישית של מעכב c–met וצורת המלח שלו ושיטה להכנתן
Warnier et al. Enabling efficient positron emission tomography (PET) imaging of synaptic vesicle glycoprotein 2A (SV2A) with a robust and one-step radiosynthesis of a highly potent 18F-labeled ligand ([18F] UCB-H)
IL294136A (he) תרכובת פיירידאזינייל-תיאזולקרבואקסמיד
UA116644C2 (uk) Сполуки біариламіду як інгібітори кінази
IL289951B1 (he) תרכובת אוריאה כאנטגוניסט של קולטן lpa1
IL276545A (he) שיטה לטיפול בסרטן
EP3828183A1 (en) Sulfoximine compound as bromodomain protein inhibitor and pharmaceutical composition and medical use thereof
JP2014519489A (ja) 画像診断のための放射性標識アミノ酸
EP3774722B1 (en) Opioid receptor modulators and products and methods related thereto
Kuranov et al. Exploring bulky natural and natural-like periphery in the design of p-(benzyloxy) phenylpropionic acid agonists of free fatty acid receptor 1 (GPR40)
TW202233591A (zh) 2-吡啶酮及其使用方法
JP2024543013A (ja) Ｒｘｆｐ１アゴニスト
JP2022511269A (ja) シャペロン介在性オートファジー調節剤として有用な化合物
IL315993A (he) נגזרת טטראהידרונפתלן
JP2019512550A (ja) エストロゲン受容体ダウンレギュレーターとしての置換インドール化合物
JP2020508981A (ja) ビアリール化合物、その製造方法及び用途
JP2025501509A (ja) Ｒｘｆｐ１受容体アゴニストとしてのベンゾチアゾール、ベンゾイソオキサゾールおよびベンゾジオキソールアナログ
JP2024517473A (ja) Ｙａｐ／ｔｅａｄの調節のための化合物及び方法ならびにそれらの適用
CN118401496A (zh) 作为rxfp1激动剂的四氢化萘、苯基环丁烷和苯基环戊烷类似物
CN115745983A (zh) 一种血管紧张肽和内皮肽受体拮抗剂及其应用
CN118176197A (zh) 用于治疗心力衰竭的rxfp1调节剂